BetterLife Pharma delays annual shareholder meeting to Dec. 9

• BetterLife Pharma delayed its annual shareholder meeting to Dec. 9, 2026 from Oct. 14, 2026.
• Meeting reclassified as an annual general and special meeting to add shareholder votes tied to Nasdaq listing requirements.
• Record date reset to Oct. 26, 2026; updated proxy materials targeted for distribution around Nov. 9, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BetterLife Pharma Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609291759NEWSFILECNPR____20260929_316698_1) on September 29, 2026, and is solely responsible for the information contained therein.